课题基金 / 基金详情

Evaluating Individual Cancer-associated Thrombosis Mechanisms to Inform Personalized Thromboprophylaxis in Patients with Metastatic Bone Disease

Evaluating Individual Cancer-associated Thrombosis Mechanisms to Inform Personalized Thromboprophylaxis in Patients with Metastatic Bone Disease
评估个体癌症相关血栓形成机制,为转移性骨病患者的个性化血栓预防提供信息
批准号:
469094
负责人:
Schneider Prism S
金额:
$76.03万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01

项目摘要

项目成果

Schneider Prism S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Due to medical advancements, patients with cancer are living longer; however, this results in metastatic bone disease (MBD) being more common, which can lead to cancer-associated fractures. These fractures often require surgical treatment. Both cancer and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating Individual Cancer-associated Thrombosis Mechanisms to Inform Personalized Thromboprophylaxis in Patients with Metastatic Bone Disease
  • 批准号:
    465447
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Schneider Prism S
  • 依托单位:
HIP fracture thromboPROphylaxis (HIP PRO) Pilot: A Pilot Randomized Controlled Trial
  • 批准号:
    462840
  • 项目类别:
    Operating Grants
  • 资助金额:
    $42.08万
  • 财政年份:
    2022
  • 负责人:
    Schneider Prism S
  • 依托单位:
Quantification of the Duration of Increased Risk for Venous Thromboembolism in Patients with Femur Fractures Using Thrombelastography
  • 批准号:
    410471
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.8万
  • 财政年份:
    2019
  • 负责人:
    Schneider Prism S
  • 依托单位:
Thrombelastography-Defined Duration of Hypercoagulability Following Pelvis and Acetabular Fractures
  • 批准号:
    418364
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2019
  • 负责人:
    Schneider Prism S
  • 依托单位:
海外基金